Pharma Value Special: The new HTA Regulation
Special European HTA Regulation The new European Regulation on Health Technology Assessment (HTA-r) 2021/2282, which comes into force on 12 January 2025, marks an important step
9 July 2024
Special European HTA Regulation The new European Regulation on Health Technology Assessment (HTA-r) 2021/2282, which comes into force on 12 January 2025, marks an important step
Update 17 June 2024 Below are the appointments updated to 17 June 2024. On the AIFA website you can read the new determination of 17/06 that
Update 1 March 2024 Below is the updated document with nominations and update timeline to 1 March 2024. Original text Pharma Value has developed with Nomos a document of
In collaboration with Rarelab, we launched a survey with the aim of assessing the actual impact of the use of comparators in the negotiation of orphan drugs, drugs that for
Yesterday, 15 January 2024, the Ministerial Decree for the reform of AIFA was published in the OJ. It will enter into force on 30 January 2024. The Ministerial Decree
On Tuesday 12 December 2023, the 7th Ossfor Annual Report, produced by Omar -
It was approved last night, in the Council of Ministers of Wednesday 27 September 2023, as part of the Urgent Provisions on the Extension of Regulatory Deadlines
On 12 September, the 'AIFA Incontra' initiative was held at the agency's institutional headquarters in Via del Tritone, a new way of dialogue in transparency
Update 20 November 2023 The extraordinary State-Regions Conference held on 16 November 2023 sanctioned the long-awaited agreement on the Minister of Health's draft regulation,
The official European Commission proposal is scheduled to be published on 29 March 2023, but during the World Evidence, Pricing and Access Congress -
